HBOT Conversations:
Elena Schertz & Extivita RTP
Elena Schertz, NP of Extivita-RTP in North Carolina, discusses how her clinic is actively healing the injured and sick with hyperbaric oxygen therapy (HBOT), including veterans, sports athletes and COVID long-haulers. She explains the proven benefits of HBOT – what it is, who are candidates for the therapy, and how each session saturates a patient’s blood plasma with oxygen for ultimate healing powers.
Extivita-RTP offers a positive environment for healing, and she encourages anyone seeking a better quality of life to come visit them and experience the wonder of hyperbaric oxygen therapy.
Watch the Podcast
HBOT News podcast host, Edward diGirolamo, talks with guest, Elena Schertz, NP of Extivita-RTP, about how her clinic is actively healing the injured and sick with hyperbaric oxygen therapy (HBOT), including veterans, sports athletes and COVID long-haulers. She explains the proven benefits of HBOT – what it is, who are candidates for the therapy, and how each session saturates a patient’s blood plasma with oxygen for ultimate healing powers.
Elena reveals their successes treating TBI and PTSD, and why the therapies at Extivita are even leading to the patient’s elimination of suicidal thoughts. Since veterans are at high risk of suicide due to the grave nature of combat, priority is being taken to treat these American heroes with HBOT at low or no cost. North Carolina’s veteran funding is discussed, while Elena expresses her hope that the state will eventually expand funding to include other beneficial therapies.
The topic of treating COVID long-haulers arise, and Elena makes a claim with absolute certainty that 99% of the COVID long-haulers who come through their doors are significantly better after going through HBOT sessions and nutritional IV regiments, with 95% of them eventually returning to their baseline.
Elena ends the podcast interview raving about her experienced clinical staff, explaining how they celebrate every milestone with their patients relishing in the rewards of making a difference and saving lives. They offer a positive environment for healing, and she encourages anyone seeking a better quality of life to come experience Extivita-RTP and the wonder of hyperbaric oxygen therapy.
Guest
Elena Schertz, NP - Clinic Manager at Extivita RTP
Elena attained her Bachelors of Science in Nursing from Michigan State University and received her Masters of Science in Nursing from Simmons University in Boston, MA. She has been practicing integrative medicine since 2010 and is currently working on her certification in functional medicine from the Institute of Functional Medicine.
Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.
Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.
Extivita-RTP – Hyperbaric Oxygen Therapy Clinic
2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/
Subscribe Now, It’s Free !
Recent HBOT News
With $2M grant, Fargo clinic hopes to expand access to head injury treatment in its high-pressure chambers
Article from Inforum (Fargo, ND) highlights a $2M grant to help expand access to Hyberbaric Oxygen Therapy (HBOT) to treat head injuries at a clinic in North Dakota: After a series of four concussions in just two years, 13-year-old Payton Rude's health wasn't...
Clinical Trial – Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy
This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E
immediately after completion of radiation therapy to evaluate which treatment best reduces
radiation fibrosis.
The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms
The National Brain Injury Rescue and Rehabilitation Project was established as a preliminary study to test the safety and practicality of multi-center hyperbaric oxygen administration for the post-concussive symptoms of chronic mild traumatic brain injury as a precursor to a pivotal, independent, multi-center, controlled clinical trial. This report presents the results for 32 subjects who completed a preliminary trial of hyperbaric oxygen several years before the passage of the 21 st Century Cures Act. This study anticipated the Act and its reassessment of clinical research. Subjects received 40-82 one-hour treatments at 1.5 atmospheres absolute 100% oxygen. Outcome measures included repeated self-assessment measures and automated neurocognitive tests. The subjects demonstrated improvement in 21 of 25 neurocognitive test measures observed. The objective neurocognitive test components showed improvement in 13 of 17 measures. Earlier administration of hyperbaric oxygen post injury, younger age at the time of injury and hyperbaric oxygen administration, military status, and increased number of hyperbaric oxygen administrations were characteristics associated with improved outcomes. There were no adverse events. Hyperbaric oxygen was found to be safe, inexpensive and worthy of clinical application in the 21 st Century model of facile data collection provided by recent research regulatory shifts in medicine. The study was approved by the ethics review committee of the Western Institutional Review Board (WIRB; Protocol #20090761).